ICU
SeaStar Medical Holding CorporationNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$14.99M
P/E Ratio
—
EPS
$-2.38
Beta
-1.02
52W High
$13.00
52W Low
$2.07
50-Day MA
$3.78
200-Day MA
$4.55
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation (ICU) is an innovative biotechnology company committed to improving treatment options for chronic kidney disease through its proprietary technologies aimed at enhancing renal function and minimizing the need for invasive procedures. Operating in a growing market with significant unmet medical needs, SeaStar is dedicated to clinical innovation and excellence. Supported by a strong research and development pipeline and strategic collaborations, the company is well-positioned to make impactful advancements in renal health and expedite the commercialization of its groundbreaking therapies.
Fundamentals
| Revenue (TTM) | $1.44M |
| Gross Profit (TTM) | $1.34M |
| EBITDA | — |
| Operating Margin | -728.00% |
| Return on Equity | -302.00% |
| Return on Assets | -79.20% |
| Revenue/Share (TTM) | $0.51 |
| Book Value | $1.83 |
| Price-to-Book | 2.05 |
| Price-to-Sales (TTM) | 10.44 |
| EV/Revenue | 4.159 |
| EV/EBITDA | -8.13 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 68.90% |
| Shares Outstanding | $4.00M |
| Float | $3.95M |
| % Insiders | 0.99% |
| % Institutions | 7.66% |
Historical Volatility
HV 10-Day
73.23%
HV 20-Day
83.89%
HV 30-Day
97.55%
HV 60-Day
114.96%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($10.00 target)
1
Strong BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026